Skip to main content
. 2022 Jan 26;13:837977. doi: 10.3389/fimmu.2022.837977

Figure 2.

Figure 2

CFA-induced inflammatory pain and paw inflammation was attenuated by JQ1, the BRD4 inhibitor. (A) Experimental design to test the antinociceptive effects of BRD4 inhibitor JQ1 in the CFA-induced inflammatory pain model. (B, C) Effects of BRD4 inhibitor JQ1 on thresholds of mechanical allodynia (B) and thermal hyperalgesia (C). Tests were carried out before CFA injection and on days 1, 3,and 7, n=6 mice/group. (D) Inflammation in mouse paw tissues by H&E staining, n=3 mice/group, all figures were magnified by 400×. Data were presented as mean ± standard deviation (SD). (**P < 0.01, ***P < 0.001).